1. Home
  2. DSC vs ACIU Comparison

DSC vs ACIU Comparison

Compare DSC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSC

DSC Holdings Ltd. American Depositary Shares

HOLD

Current Price

$4.92

Market Cap

293.4M

Sector

Technology

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

SELL

Current Price

$2.40

Market Cap

247.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DSC
ACIU
Founded
2013
2003
Country
China
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.4M
247.6M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
DSC
ACIU
Price
$4.92
$2.40
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $8.57
AVG Volume (30 Days)
40.0K
★ 194.2K
Earning Date
12-18-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.21
$422.39
Revenue Next Year
$56.22
$377.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$2.10
52 Week High
$9.60
$4.00

Technical Indicators

Market Signals
Indicator
DSC
ACIU
Relative Strength Index (RSI) 34.28 37.63
Support Level N/A $2.13
Resistance Level $7.00 $2.41
Average True Range (ATR) 0.82 0.14
MACD -0.11 -0.03
Stochastic Oscillator 4.87 8.49

Price Performance

Historical Comparison
DSC
ACIU

About DSC DSC Holdings Ltd. American Depositary Shares

DSC Holdings Ltd is an AI application infrastructure for China's used car industry. According to CIC, the Company has held over 90% market share in operating systems for China's used car dealers, giving it nationwide dealer connections and massive, granular, proprietary, real-time industry data. Building on this digital foundation, the group further supports used car dealers with essential transaction services across their workflows. Its Services engage and benefit thousands of dealer collaborators, such as inspectors, transporters, and other internet platforms, creating an ecosystem with used car dealers at its center.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: